(CGM) Cegedim S.A. - Ratings and Ratios

Cegedim S.A. is a technology and services company that specializes in managing digital data flow within the healthcare ecosystem and B2B sectors. The company operates through two primary segments: Health Insurance, HR and e-Services, and Healthcare Professionals. The former provides a range of products and services to insurance companies, mutual insurers, and healthcare professionals, including hosting solutions, HR and payroll management outsourcing, electronic data exchange, and data processing services. The latter offers software solutions, databases, and other services tailored to the needs of doctors, paramedical professionals, pharmacists, and healthcare facilities. With a history dating back to 1969, Cegedim S.A. is headquartered in Boulogne-Billancourt, France, and operates under the umbrella of its parent company, FCB SAS.

From a market perspective, Cegedim S.A.s stock (CGM) is classified under the Health Care Technology sub-industry, reflecting its focus on healthcare technology solutions. The companys operational footprint spans France, other European countries, and international markets, positioning it as a significant player in the global healthcare technology landscape.

Analyzing the provided technical data, the stocks current price is €11.50, indicating a potential downward trend given its position relative to its SMA20 (€11.66), SMA50 (€12.24), and SMA200 (€12.29). The Average True Range (ATR) stands at 0.51, or 4.41%, suggesting moderate volatility. The stocks 52-week high and low are €14.40 and €10.50, respectively, showing a considerable range in price movements over the past year.

Fundamentally, Cegedim S.A. has a market capitalization of €164.50M and a forward P/E ratio of 11.81, which may indicate undervaluation relative to its earnings potential. However, the companys Return on Equity (RoE) is -5.11%, signaling negative profitability. This discrepancy between the forward P/E and RoE suggests that the market may be anticipating a turnaround in the companys financial performance.

Forecasting Cegedim S.A.s stock performance based on the available technical and fundamental data, a potential trend reversal could occur if the company addresses its negative RoE. Assuming a successful turnaround, the stock could see an upward trajectory, potentially targeting the SMA50 or SMA200 levels (€12.24 and €12.29, respectively) in the short to medium term. However, failure to improve profitability could lead to further declines, potentially testing the 52-week low of €10.50. Thus, the key catalyst for the stocks direction will be the companys ability to enhance its financial health and return to profitability.